Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Share News

ImmuPharma Interim Loss Widens On Higher Costs And Lower Revenue

26th Sep 2018 12:40

LONDON (Alliance News) - ImmuPharma PLC said on Wednesday it continues to progress its lupus treatment Lupuzor, as it saw a widened loss for the first half of 2018 due to higher costs and lower a Read More

ImmuPharma Inks Pact With Incanthera For Nucant Cancer Programme

7th Sep 2018 11:43

LONDON (Alliance News) - ImmuPharma PLC said Friday it signed a clinical development collaboration for the Nucant cancer programme with Incanthera Ltd, a specialist oncology development the terms Read More

Immupharma Says P140 Peptide Shows Positive Results In CIDP Treatment

14th Jun 2018 12:02

LONDON (Alliance News) - ImmuPharma PLC said Thursday that its pre-clinical studies of the P140 peptide showed positive results in the treatment of chronic inflammatory demyelinating were trading Read More

ImmuPharma Excited Despite Widened Loss As Lupuzor Makes Good Results

29th May 2018 09:40

LONDON (Alliance News) - ImmuPharma PLC said Tuesday it continues to be "excited" by its future potential despite a widened loss for 2017.The drug development company reported a a Read More

ImmuPharma Prepares To Report Lupuzor Study Results In April

23rd Mar 2018 11:17

LONDON (Alliance News) - Drug development company ImmuPharma PLC said on Friday it has been informed by Simbec-Orion that the data-base lock for the Lupuzor pivotal phase III Read More

ImmuPharma Says Paper Detailing IPP-204106 Mechanism Published

16th Nov 2016 10:41

Read More

ImmuPharma Makes Progress With Lupuzor Phase III Trial

14th Sep 2016 08:45

Read More

ImmuPharma Begins Dosing Of European Patients In Lupuzor Trial

7th Jun 2016 06:59

Read More

AGM, EGM Calendar - Week Ahead

18th May 2016 15:05

Read More

ImmuPharma 2015 Loss Widens As It Focuses On Lupuzor Development

4th May 2016 09:17

Read More

Earnings, Trading Statements Calendar - Week Ahead

27th Apr 2016 15:06

Read More

ImmuPharma Begins Patient Recruitment In Europe For Lupuzor Trial

9th Mar 2016 10:27

Read More

ImmuPharma Hopeful As US Patients Begin Dosing In Lupus Clinical Trial

15th Feb 2016 09:02

Read More

WINNERS & LOSERS SUMMARY: Just Eat Leaps As It Gobbles Up Takeaways

5th Feb 2016 10:32

Read More

ImmuPharma Looks To Raise Minimum GBP7.5 Million In Equity (ALLISS)

5th Feb 2016 08:34

Read More

ImmuPharma Says US Sites Open For Lupuzor Phase III Trial Recruitment

7th Dec 2015 09:36

Read More

WINNERS & LOSERS SUMMARY: Housebuilders And Estate Agents Torn Down

4th Nov 2015 10:31

Read More

ImmuPharma Says Lupuzor Trials Set To Start In US This Year

4th Nov 2015 08:56

Read More

ImmuPharma Appoints Non-Executive Chairman As Loss Narrows

30th Sep 2015 09:29

Read More

ImmuPharma Says Chairman And Co-Founder Richard Warr Dies

29th Jul 2015 09:16

Read More

FTSE 100 Latest
Value9,491.25
Change63.52